Olink

Olink®
Part of Thermo Fisher Scientific

Plasma IL-24 is associated with time to first fall in Parkinson's disease

Journal of Neuroimmunology, 2026

Iwaoka K., Taguchi K., Oikawa S., Toyoshiba H., Ando T., Maeda T.

Disease areaApplication areaSample typeProducts
Neurology
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

Plasma inflammatory protein biomarkers associated with clinical milestone heterogeneity in Parkinson’s disease (PD) remain undefined. We measured 92 inflammation-related plasma proteins in 82 PD patients using the Olink Proximity Extension Assay. No proteins differed significantly between fallers and non-fallers. However, among fallers, plasma interleukin-24 showed the strongest correlation with observed time to first fall (unadjusted r = 0.752, q = 0.071), and this signal was also observed in an exploratory covariate-adjusted model (q = 0.030). Colony-stimulating factor 1 showed a comparable but non-significant correlation. In group comparisons for symptomatic orthostatic hypotension, CCL11 differed significantly between patients with and without symptomatic orthostatic hypotension (q = 0.0004). These exploratory findings highlight candidate inflammatory protein profiles related to milestone heterogeneity in PD, warranting validation in longitudinal cohorts.

Read publication ↗